Abbott Laboratories Aktie
WKN: 850103 / ISIN: US0028241000
16.10.2024 13:34:20
|
Abbott Laboratories Q3 Profit Increases, Beats Estimates
(RTTNews) - Abbott Laboratories (ABT) revealed earnings for its third quarter that increased from the same period last year and beat the Street estimates.
The company's earnings came in at $1.646 billion, or $0.94 per share. This compares with $1.436 billion, or $0.82 per share, in last year's third quarter.
Excluding items, Abbott Laboratories reported adjusted earnings of $2.119 billion or $1.21 per share for the period.
Analysts on average had expected the company to earn $1.20 per share, according to figures compiled by Thomson Reuters. Analysts' estimates typically exclude special items.
The company's revenue for the quarter rose 4.9% to $10.635 billion from $10.143 billion last year.
Abbott Laboratories earnings at a glance (GAAP) :
-Earnings (Q3): $1.646 Bln. vs. $1.436 Bln. last year. -EPS (Q3): $0.94 vs. $0.82 last year. -Revenue (Q3): $10.635 Bln vs. $10.143 Bln last year.
-Guidance: Next quarter EPS guidance: $1.31 to $1.37 Full year EPS guidance: $4.64 to $4.70

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Abbott Laboratoriesmehr Nachrichten
24.07.25 |
NASDAQ Composite Index-Papier Abbott Laboratories-Aktie: So viel Gewinn hätte ein Investment in Abbott Laboratories von vor einem Jahr eingebracht (finanzen.at) | |
18.07.25 |
Minuszeichen in New York: So entwickelt sich der S&P 500 am Freitagnachmittag (finanzen.at) | |
18.07.25 |
NASDAQ-Handel: NASDAQ Composite legt zum Start des Freitagshandels zu (finanzen.at) | |
17.07.25 |
Börse New York: NASDAQ Composite beendet den Handel im Plus (finanzen.at) | |
17.07.25 |
Zuversicht in New York: S&P 500 zeigt sich letztendlich fester (finanzen.at) | |
17.07.25 |
Gewinne in New York: NASDAQ Composite legt zu (finanzen.at) | |
17.07.25 |
S&P 500 aktuell: Am Nachmittag Pluszeichen im S&P 500 (finanzen.at) | |
17.07.25 |
Gute Stimmung in New York: NASDAQ Composite verbucht mittags Zuschläge (finanzen.at) |
Analysen zu Abbott Laboratoriesmehr Analysen
Aktien in diesem Artikel
Abbott Laboratories | 111,98 | 1,56% |
|